Kindstar to Offer RNA-based Cancer Diagnostics in China

Kindstar Global, the China diagnostic testing lab, will begin validating and implementing two cancer tests developed by Advanced Cell Diagnostics of California. Both tests belong to ACD’s RNAscope® platform of molecular diagnostic assays. Kindstar will offer the assays, which it calls a “new generation of cancer diagnostic tests,” through its network of more than 3,300 China hospitals. More details.... Share this with colleagues: // //